Thomas Catinazzo
2021
In 2021, Thomas Catinazzo earned a total compensation of $1.8M as Chief Financial Officer at Relay Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $166,731 |
|---|---|
| Option Awards | $734,038 |
| Salary | $381,100 |
| Stock Awards | $543,548 |
| Other | $10,862 |
| Total | $1,836,279 |
Catinazzo received $734K in option awards, accounting for 40% of the total pay in 2021.
Catinazzo also received $166.7K in non-equity incentive plan, $381.1K in salary, $543.5K in stock awards and $10.9K in other compensation.
Rankings
In 2021, Thomas Catinazzo's compensation ranked 6,373rd out of 12,415 executives tracked by ExecPay. In other words, Catinazzo earned more than 48.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,373 out of 12,415 | 49th |
Division Manufacturing | 2,718 out of 5,508 | 51st |
Major group Chemicals And Allied Products | 1,197 out of 2,378 | 50th |
Industry group Drugs | 1,065 out of 2,099 | 49th |
Industry Biological Products, Except Diagnostic Substances | 259 out of 449 | 42nd |
Source: SEC filing on April 14, 2022.
Catinazzo's colleagues
We found four more compensation records of executives who worked with Thomas Catinazzo at Relay Therapeutics in 2021.